The Rising Prevalence of Lymphedema in Canada: A continuing dialogue.
Pathways · 2017
DOI: 10.70472/aqhu5357 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathways, 2017. Verfasst von David Keast und 1 weiteren Autor:innen.
Abstract (Originalsprache)
This article explores the prevalence of lymphedema and chronic edema in Canada, emphasizing the challenges in obtaining accurate estimates due to diverse causes and complex diagnostic criteria. Authors Keast and Towers address multiple prevalence factors, particularly highlighting the significant role of obesity, which surpasses cancer as the primary contributor to lymphedema cases in Canada. Additional risk factors include chronic venous insufficiency, reduced mobility, and certain types of surgeries. While prevalence estimates vary, conservative figures suggest over a million Canadians may be affected. The authors advocate for improved prevention, screening, and management strategies and call for greater research to refine prevalence data and inform healthcare policy.
Zitieren
APA
Keast, D., & Towers, A. (2017). The Rising Prevalence of Lymphedema in Canada: A continuing dialogue. Pathways. https://doi.org/10.70472/aqhu5357
Vancouver
Keast D, Towers A. The Rising Prevalence of Lymphedema in Canada: A continuing dialogue. Pathways. 2017. doi:10.70472/aqhu5357
BibTeX
@article{Keast2017,
author = {Keast, David and Towers, Anna},
title = {The Rising Prevalence of Lymphedema in Canada: A continuing dialogue},
journal = {Pathways},
year = {2017},
doi = {10.70472/aqhu5357}
}
EUVIMED